ANDA 75569, held by Trace Life. Thallous Chloride TL-201.
As of Nov 18, 2026, ANDA 75569 (Thallous Chloride Tl 201), held by Trace Life, was first approved by FDA on Nov 21, 2001, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 21, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thallous Chloride Tl 2011mCi/ML · injectable;injection | Thallous Chloride TL-201 | Discontinued |
| Aug 6, 2008 | Supplement 1Manufacturing | Approved | None posted |
| Aug 6, 2008 | Supplement 2Labeling | Approved | None posted |
| Nov 21, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters